TG Therapeutics Inc (NASDAQ:TGTX) currently has a daily average trading volume of 2.33M but it saw 1860582 shares traded in last market. With a market cap of 6.02B USD, the company’s current market price of $37.92 came rising about 6.49 while comparing to the previous closing price of $35.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $46.48 and as low as $16.65. In the recent trading on the day, stock has struck highest price mark of $35.4346 while lowest mark touched by it was $37.94.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the TD Cowen which initiated the stock as “Buy” in its note to investors issued on October 29, 2024, recommending a price target of $50 for it. Goldman upgraded its recommendation for the stock as a “Neutral” from “Sell” on August 02, 2023 while assigning a price target range of $16-$12. Jefferies issued its recommendations for the stock as it resumed the price target for the stock in the range of between $55 and $40.
Over the week, TGTX’s stock price is moving 7.12% up while it is -5.34% when we observe its performance for the past one month. Year-to-date it is 99.47% up and over the past year, the stock is showing an upside performance of 25.98%.
Currently, TG Therapeutics Inc’s total number of outstanding shares is 158.17M. Company’s return on investment (ROI) stands at 7.99% and return on equity (ROE) at 19.70%. It has a price to earnings ratio (P/E ratio) of 155.41 while having a 21.65 of forward P/E ratio. Stock’s beta reads 1.96. Stock has a price to book (P/B) ratio of 25.28 while price to sale or P/S ratio amounts to 15.58. Its return on asset (ROA) is 7.60% on average.
